- David Chen
- Founder&Managing Director
- BFC Group
- Christina Zhang
- Partner in Charge - Shanghai
- Cooley
- Yifu Liu
- Executive Director
- OrbiMed
- Guillaume Vignon
- Guillaume Vignon, Global Head BD&L Partnering - Strategy & Growth
- Novartis
- Matthieu Merlin
- Global Head of Business Development, General Medicines
- Sanofi
- Lila Hope
- Partner
- Cooley
- Mark A. Emalfarb
- President and Chief Executive Officer
- Dyadic International
- Roby
- Head of Technologies and Externalizations at Global Business Development and Alliance Management
- EMD Serono
- Lili Zheng
- International Tax Partner
- Deloitte
- David Preston
- Chairman & Founder
- Jingrui Group
- Thijs Spoor
- CEO
- Viewpoint
- Jia En Chin
- Executive Director
- BFC Group
- Petrina Kamya
- Head of AI Platforms
- Insilico Medicine
- Diana Pignalosa
- Head of Strategic Partnering
- Debiopharm
- Guillaume Vignon
- Global Head BD&L Partnering
- Novartis
- Denny Won
- Partner
- Cooley
- Huaizheng
- MD, PhD, General Director of International Investment and Operation
- China Medical System Holdings
- Yiming Liu
- Partner
- Cooley
- Huaizheng Peng
- Chief Business Officer
- China Medical System Holdings
- Markus Puhlmann
- Chief Medical Officer
- Viewpoint Molecular Targeting
- Betty Huang
- VP and Head of Collaborate to Cure Hub China within BD&L and Open Innovation
- Bayer Pharmaceuticals
- Jake Bcraft
- Co-founder & CEO
- Strand Therapeutics
- Detlev Mennerich
- SVP and Head of Global BD&L
- Boehringer Ingelheim
- Michael Flaschen
- SVP, Global External Innovation
- Daiichi Sankyo
- John Mayfield
- Chief Business officer
- Be Biopharma
- John Whittaker
- Managing Director, Global Healthcare Investment Banking
- J.P. Morgan
- Jeff Zhou
- Executive Director, China Healthcare Investment Banking
- J.P. Morgan
- Amit Kakar
- Senior Partner, Head of Novo Holdings Asia
- Novo Holdings Equity Asia
- Albert Ren
- Vice President, Strategy and Business Development
- Pfizer China